Christopher O’Callaghan

机构：Queen's University, Great Ormond Street Hospital, Canadian Partnership Against Cancer, Leicester General Hospital, University Hospitals of Leicester NHS Trust, University of Oxford, Institute of Infection and Immunity, Canadian Cancer Trials Group, University College London · ORCID：0000-0002-8633-2473

发表论文 233 篇 · 总被引 11173 次 · h-index 52

代表论文

• Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids (2024 · Nature Medicine · 被引 46)
• Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing (2023 · Molecular Therapy — Methods & Clinical Development · 被引 13)
• Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa (2024 · Molecular Therapy · 被引 11)
• Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2024 · Nature Communications · 被引 11)
• NEMA NU 2-2018 evaluation and image quality optimization of a new generation digital 32-cm axial field-of-view Omni Legend PET-CT using a genetic evolutionary algorithm (2024 · Biomedical Physics & Engineering Express · 被引 9)
• Primary ciliary dyskinesia: a national expert consensus statement on standards of care (2025 · ERJ Open Research · 被引 5)